🇨🇭 We're proud to have been selected by the jury to be part of the Swiss National Startup team at Venture Leaders Biotech 2022. 🚀 We'll be sharing our innovative #woundcare approach on August 18th at the virtual pitch event, sign up to join us here: bit.ly/3BuExJ9 👀

We are proud to present to you: the Swiss National Startup Team, representing Switzerland in the USA! Meet the winners of Venture Leaders Biotech 2022 traveling to Boston: venturelab.swiss/Venture-Leader… #VLeadersBiotech #SwissStartups #Boston #USA

Meet the Swiss National Startup Team, representing Switzerland in the Biotech Boston Area, USA! Get your free ticket for the virtual pitches, on Thursday, August 18th at 2:00pm (CET) / 8:00am(EST): venturelab.swiss/index.cfm?page… Welcoming the #VLeadersBiotech: venturelab.swiss/Venture-Leader…

With a month to go, we're excited to take part in this fantastic opportunity 🚀

📣 @Venturelab Biotech Pitch Session is scheduled on 18 August. ▶️ Meet Alentis Therapeutics, Bionomous, Bionter, FimmCyte, healiva® , InCephalo, Interax Biotech, lino Biotech AG, @RecolonyAG and Vanarix. bioalps.org/pitch-session-…

🏥Up to 68% of combat trauma amputees are later diagnosed with wound infections. A new study in Nature Communications outlines a novel approach to understanding the bacterial bioburden in these cases. Read the article in full here: nature.com/articles/s4159…

We had an exciting day yesterday filming for #BusinessInEurope on #RTL7. 🗞️ More news coming soon, stay tuned! #woundcare #woundmanagement

⚙️We're gearing up for the Venturelab #biotech roadshow to be held in Boston! Find out more about the team representing🇨🇭 here: swissnex.org/boston/news/te…

The 9th Annual Sachs Associates #healthtech investment forum is being held in person in🇨🇭Basel on the 20th September. Priyanka Passecker will be there representing healiva, do come and say hello to learn about our vision for the future of #woundcare 🩹 👉 bit.ly/3wBLFQi

From parachuting and helicopters, to 19th century Bengali poetry, these are only some of the surprising facts found in our founder's Priyanka Passecker Venturelab interview as we gear up for Boston. 🙌 Read the introductory interview in full here: bit.ly/3RqUx3e

The The Royal Society of Medicine has a fantastic free resource on venous disease, including a three part webinar series found here: bit.ly/3eofuOa Follow the link to learn more about this >£1 billion annual burden on the #NHS #woundmanagement #HealLife

Digital Medicine Market is estimated to be US$ 18.6 Billion by 2029 with a CAGR of 23.5%. TO KNOW MORE: bit.ly/3qiQmuT KEYPLAYERS: eClinicalWorks,McKesson Corporation. EMERGING PLAYERS: ProteusDigitalHealth,healiva®. #wirelesshealth #mobilehealth #digitalhealth #artificialintelligence

Over a million people saw news of our acquisition of wound healing cell therapy assets this summer 🙌 Did you? 🤔 Check out the International Wound Journal's coverage here: bit.ly/3xaGO96

healiva offers end-to-end solutions for wound care. We talked to Venture Leader Biotech Priyanka Dutta-Passecker, member of the Swiss National Startup Team, getting ready for the roadshow to Boston: venturelab.swiss/Healiva-The-Ve… #VLeadersBiotech #SwissStartup

We're delighted to announce that Anna Sisti has joined healiva as Quality Manager. 🙌Welcome to the team!

The #VLeadersBiotech Roadshow has finished with a great week full of meetings, visits, strategic workshops, and after works with such an amazing team! Bionomous InterAx healiva® @RecolonyAG #VLeadersBiotech #SwissStartups #BioTech #Boston #USA

Exciting week with #VLeadersBiotech Venturelab #investors #boston #roadshow healiva®

We continue to accelerate the launch of Healiva’s personalised skin regeneration therapy, EpiDex. Today, we announce the acquisition of critical #manufacturing cell banks from @bbraun_com. Read here: rb.gy/rax0pk #celltherapymanufacturing #chronicwounds

This will allow us to deliver our clinically proven, surgery-free solution to patients with severe chronic wounds more promptly, shortening the path to market for EpiDex by approximately one year. businesswire.com/news/home/2022…

Healiva’s technology represents a significant opportunity to change the way we treat people with chronic wounds businesswire.com/news/home/2023…